Multispecific drugs herald a new era of biopharmaceutical innovation
Crossref DOI link: https://doi.org/10.1038/s41586-020-2168-1
Published Online: 2020-04-15
Published Print: 2020-04-16
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Deshaies, Raymond J. https://orcid.org/0000-0002-3671-9354
Text and Data Mining valid from 2020-04-15
Version of Record valid from 2020-04-15
Article History
Received: 24 November 2019
Accepted: 27 February 2020
First Online: 15 April 2020
Competing interests
: R.J.D. is an employee, officer and shareholder of Amgen.